Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

Tal Medical appoints president and CEO

Tal Medical, Inc., a clinical stage medical device company, has appointed Jan Skvarka as president, CEO and member of the board of directors, and Ben Shapiro as a member of the board of directors.

Published By MarketLine
22 Apr 2014
NewsWire
NewsWire

Cubist Pharmaceuticals recalls one lot of skin infection drug

Cubist Pharmaceuticals, Inc., a biopharmaceutical company, has announced the voluntarily recall of one lot of CUBICIN 500mg in 10mL single use vials to the user level due to the presence of particulate matter, reported via customer complaint and identified as glass particles, found in a single vial from this lot, produced by a contract manufacturer.

Published By MarketLine
22 Apr 2014
NewsWire
NewsWire

VuCOMP installs new mammography system at Capital Imaging Associates

VuCOMP, Inc., a developer of cancer detecting technologies, has installed its new M-Vu CAD, or computer-aided detection, for mammography at Capital Imaging Associates.

Published By MarketLine
22 Apr 2014
NewsWire
NewsWire

Covidien recalls Pipeline Embolization Device and Alligator Retrieval Device

Covidien plc, a provider of healthcare products, has announced the voluntary recall of certain lots of its Pipeline Embolization Device and Alligator Retrieval Device where the polytetrafluoroethylene, or PTFE, coating applied to the delivery wire could delaminate and detach from the devices.

Published By MarketLine
22 Apr 2014
NewsWire
NewsWire

Spectranetics receives FDA clearance for lead extraction platforms

The Spectranetics Corporation, a provider of single-use medical devices, has received FDA clearance for two new mechanical lead extraction platforms, TightRail and SightRail, which reportedly expand physicians' options for safe removal of cardiac leads.

Published By MarketLine
22 Apr 2014
NewsWire
NewsWire

Advaxis receives notices of allowances for cancer immunotherapy technology

Advaxis, Inc., a biotechnology company, has received two notices of allowances from the Japan Patent Office for patent applications related to the company's proprietary cancer immunotherapy platform technology.

Published By MarketLine
22 Apr 2014
NewsWire
NewsWire

Seno Medical receives CE mark for new opto-acoustic breast imaging system

Seno Medical Instruments, Inc., a developer of opto-acoustic technology for diagnosing breast cancer, has received the CE mark for Imagio, a new opto-acoustic imaging system, in Europe.

Published By MarketLine
22 Apr 2014
NewsWire
NewsWire

Cepheid reports net loss for Q1, updates guidance for fiscal 2014

Cepheid, a molecular diagnostics company, has reported a net loss of $9.30 million, or $0.13 loss per share, for the first quarter ended March 31, 2014, compared to a net income of $313,000, or $0 per share, for the same quarter ended March 31, 2013. For fiscal 2014, the company has updated its guidance and expects total revenue to be in the range of $446 to $461 million and net loss to be in the range of $0.43 to $0.38 per share.

Published By MarketLine
22 Apr 2014
NewsWire
NewsWire

MEDICREA launches new spinal osteosynthesis rod system in Europe

MEDICREA, a provider of orthopedic implants, has launched the UNiD, a patient-specific spinal osteosynthesis rod system, in Europe.

Published By MarketLine
22 Apr 2014
NewsWire
NewsWire

Sandlot Solutions announces five-year contract with Dialysis Clinic

Sandlot Solutions, a provider of community health interoperability and analytics solutions, has announced a new five-year contract with Dialysis Clinic, Inc., or DCI.

Published By MarketLine
22 Apr 2014

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.